TFF2 and gastric cancer: This is consistent with the previous studies which demonstrated that high expression of TFF2 was an independent indicator of poor prognosis in CCA (20) and gastric cancer patients with TFF2-expressing tumors had a significantly worse disease-free survival (11,21).